Effect of Pathogenic Mutations on the Formation of High-Order Dynamin 2 Assemblies in Living Cells.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
10 Oct 2024
Historique:
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: aheadofprint

Résumé

Mutations in dynamin 2 (DNM2) have been associated with two distinct movement disorders: Charcot-Marie-Tooth neuropathies (CMT) and centronuclear myopathy (CNM). Most of these mutations are clustered in the pleckstrin homology domain (PHD), which engages in intramolecular interactions that limit dynamin self-assembly and GTPase activation. CNM mutations interfere with these intramolecular interactions and suppress the formation of the autoinhibited state. CMT mutations are located primarily on the opposite surface of the PHD, which is specialized for phosphoinositide binding. It has been speculated that the distinct locations and interactions of residues mutated in CMT and CNM explain why each set of mutations causes either one disease or the other, despite their close proximity within the PHD sequence. We previously reported that at least one CMT-causing mutant, lacking residues

Identifiants

pubmed: 39390788
doi: 10.1021/acs.biochem.4c00262
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Per Niklas Hedde (PN)

Beckman Laser Institute and Medical Clinic, University of California, Irvine, California 92697, United States.
Department of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States.
Department of Biomedical Engineering, University of California, Irvine, California 92697, United States.

Songning Zhu (S)

Department of Biomedical Engineering, University of California, Irvine, California 92697, United States.

Barbara Barylko (B)

Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041, United States.

Chi-Li Chiu (CL)

Department of Biomedical Engineering, University of California, Irvine, California 92697, United States.

Luke T Nelson (LT)

Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96813, United States.

Michelle A Digman (MA)

Department of Biomedical Engineering, University of California, Irvine, California 92697, United States.

Joseph P Albanesi (JP)

Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041, United States.

Nicholas G James (NG)

Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96813, United States.

David M Jameson (DM)

Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96813, United States.

Classifications MeSH